ANICIA CROSS-ROBINSON: Open Payments
NPI 1114438132 · LOGANVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,653 in 171 payments from 16 companies in 2025. Trend: 2023 $157 · 2024 $94 · 2025 $2,653
Food & beverage: $2,544Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $374 |
| E.R. Squibb & Sons, L.L.C. | 20 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $362 |
| Supernus Pharmaceuticals, Inc. | 26 | $242 |
| Alkermes, Inc. | 14 | $214 |
| Otsuka America Pharmaceutical, Inc. | 10 | $209 |
| Neurocrine BioSciences, Inc. | 16 | $201 |
| Vanda Pharmaceuticals Inc. | 10 | $169 |
| Janssen Pharmaceuticals, Inc | 7 | $142 |
| Axsome Therapeutics, Inc. | 5 | $116 |
Products named: COBENFY, CAPLYTA, Qelbree, INGREZZA, ARISTADA, UZEDY, ABILIFY ASIMTUFII, SPRAVATO.
Industry payments across GA — which companies pay providers there.
